1. Metachronous testicular seminoma after radiotherapy and chemotherapy: a case report
- Author
-
Lionel D'Hondt, Marcelo Di Gregorio, Francis Lorge, Marie Cécile Nollevaux, UCL - SSS/IREC/MONT - Pôle Mont Godinne, UCL - SSS/IREC/CHEX - Pôle de chirgurgie expérimentale et transplantation, UCL - (MGD) Service d'urologie, UCL - (MGD) Service d'anatomie pathologique, and UCL - (MGD) Service d'oncologie médicale
- Subjects
Oncology ,Adult ,Male ,medicine.medical_specialty ,medicine.medical_treatment ,030232 urology & nephrology ,Physical examination ,Case Report ,Metastasis ,03 medical and health sciences ,0302 clinical medicine ,Metachronous tumors ,Testicular Neoplasms ,Surgical oncology ,Internal medicine ,Testis ,medicine ,Humans ,Chemotherapy ,medicine.diagnostic_test ,Radiotherapy ,business.industry ,Neoplasms, Second Primary ,Seminoma ,Chemoradiotherapy ,medicine.disease ,Prognosis ,Radiation therapy ,030220 oncology & carcinogenesis ,Surgery ,Radiology ,Germ cell tumors ,business - Abstract
BACKGROUND: Bilateral testicular neoplasia is rare, with an incidence ranging from 1 to 5%. Long-term survival has improved in recent years due to advanced diagnostic approaches and new therapeutic methods that are highly effective against germ cell tumors. CASE PRESENTATION: We present the case of a patient with a primary seminomatous testicular tumor, who developed a contralateral metastasis and a subsequent metachronous tumor following chemotherapy and consolidation radiotherapy treatment. CONCLUSIONS: Strict follow-up, including physical examination and ultrasound examination of the contralateral testis, enabled early diagnosis of the second tumor, giving the patient a high likelihood of a definitive cure.
- Full Text
- View/download PDF